Research Topics
| Mary L McMasterSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenström macroglobulinemiaMary L McMaster
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD MD 20892 7236, USA
Int J Cancer 122:1183-8. 2008..Polyclonal IgM may also be a marker of genetic susceptibility in WM families. Larger studies are needed to confirm these observations...- Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemiaMary L McMaster
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Clin Lymphoma Myeloma 9:19-22. 2009..Large collaborative studies are needed to confirm these findings, which present an opportunity to define the earliest lesion(s) in the WM oncogenic pathway... - Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor conditionMary L McMaster
National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Br J Haematol 139:663-71. 2007.... - Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia familiesMary L McMaster
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NIH, Department of Health and Human Services, 6120 Executive Boulevard, MSC 7236 Bethesda, MD 20892 7236, USA
Clin Cancer Res 13:5063-9. 2007.... - Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk familiesMary L McMaster
Genetic Epidemiology Branch, Bethesda, MD, 20892 7236, USA
Am J Hum Genet 79:695-701. 2006..The findings from this first linkage analysis of families at high risk for WM represent important progress toward identifying gene(s) that modulate susceptibility to WM and toward understanding its complex etiology... - Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predispositionMary L McMaster
Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health DHHS, 6120 Executive Boulevard, Bethesda, MD 20892, USA
Clin Lymphoma 5:230-4. 2005.... - Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregationRegan H Royer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Blood 115:4464-71. 2010..69-10.51) compared with unaffected family members. These data provide clues to both genetic and environmental factors that may influence development of WM. Well-designed case-control studies are needed to confirm these findings... - Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control studyOla Landgren
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
Int J Cancer 118:3095-8. 2006..However, MM itself shows significant familial aggregation, implicating the etiologic importance of this type of hematological neoplasm and perhaps MGUS in germ line genes... - Chronic immune stimulation and subsequent Waldenström macroglobulinemiaJill Koshiol
Cancer Prevention Fellowship Program, Office of Preventive Oncology, and Division of Genetic Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd, EPS 7003, MSC 7236, Bethesda, MD 20892 7236, USA
Arch Intern Med 168:1903-9. 2008..A few previous studies suggest that chronic inflammation may particularly elevate risk of the distinct non-Hodgkin lymphoma subtype Waldenström macroglobulinemia (WM)... - Prevalence, clinical aspects, and natural history of IgM MGUSMary L McMaster
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7236, USA
Cytometry B Clin Cytom 78:S91-7. 2010..Recently, a case of MBL with an IgM MGUS was reported, suggesting a close biological relationship between these entities. While much is known about MGUS overall, investigations of IgM MGUS specifically have been fragmentary... - Second cancers among 40,576 testicular cancer patients: focus on long-term survivorsLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1354-65. 2005..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors... - Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005Porcia T Bradford
Genetic Epidemiology Branch, DCEG, NCI, NIH, 6120 Executive Blvd, Room 7005, Rockville, MD 20852 7236, USA
Arch Dermatol 145:427-34. 2009..To examine incidence and survival patterns of acral lentiginous melanoma (ALM) in the United States... - Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samplesLynn R Goldin
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, MSC 7236, Bethesda, MD 20892 7236, USA
Cancer Epidemiol Biomarkers Prev 14:2402-6. 2005..We estimate that the absolute lifetime risk for a first-degree relative of an NHL case to develop NHL is 3.6% (compared with a population risk of 2.1%) and higher if the index case had an aggressive subtype of NHL... - Prevalence of monoclonal gammopathy of undetermined significance among men in GhanaOla Landgren
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Bldg EPS Room 7110, Bethesda, MD 20892 7236, USA
Mayo Clin Proc 82:1468-73. 2007.... - Familial Waldenstrom's macroglobulinemiaMary L McMaster
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Semin Oncol 30:146-52. 2003..Although limited by small numbers and a lack of systematic ascertainment and evaluation, these data are intriguing and provide a compelling basis for further study and systematic investigation of WM in families... - Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric populationMary L McMaster
Genetic Epidemiology Branch, Human Genetics Program, Division of Cancer Epidemiologyand Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
J Med Genet 48:444-9. 2011..Reports of chordoma in children with TSC suggest that TSC1 and TSC2 mutations may contribute to chordoma aetiology... - Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in SwedenSigurdur Y Kristinsson
Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden
Blood 112:3052-6. 2008..Our findings of highly increased risks of developing LPL/WM, NHL, CLL, and MGUS support the operation of shared susceptibility genes that predispose to LPL/WM and other lymphoproliferative disorders... - Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. menSophie D Fossa
Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Norway
J Natl Cancer Inst 97:1056-66. 2005..We evaluated the risk of contralateral testicular cancer and survival in a large population-based cohort of men diagnosed with testicular cancer before age 55 years... - No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemiaDavid Ng
Br J Haematol 137:173-5. 2007 - Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRoger G Owen
Leeds General Infirmary, Leeds, UK
Semin Oncol 30:110-5. 2003..Patients with clinical features attributable to IgM monoclonal gammopathy but no overt evidence of lymphoma are considered to constitute a distinct clinical group and the term "IgM-related disorders" is proposed...